Stay updated on Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer’s website revision identifier changes from v3.7.2 to v3.8.0, reflecting a platform release update.
    Difference
    0.1%
    Check dated 2026-11-01T01:52:03.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A site-wide NIH notice appears above the study record, announcing a website transition and the use of “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.4%
    Check dated 2026-10-25T01:52:29.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-18T01:39:02.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The study is now marked **Completed**, replacing its previous **Active, not recruiting** status. A new record version dated 2026-10-07 also logs updates to study identification, recruitment status, study status, and IPD sharing.
    Difference
    0.5%
    Check dated 2026-10-11T02:06:51.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    An updated revision entry, Revision: v3.7.0, was added to the study record history, indicating a new version of the record. The previous revision, Revision: v3.6.6, was removed as part of this update.
    Difference
    0.1%
    Check dated 2026-09-20T01:05:16.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6, indicating a new build of the ClinicalTrials.gov interface for this record.
    Difference
    0.1%
    Check dated 2026-08-29T20:17:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.